{{drugbox
| IUPAC_name = 1-(4-Fluorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one
| image = FPVP.svg
| width = 200px
| CAS_number = 850352-31-7
| ATC_prefix =
| ATC_suffix =
| PubChem = 11322641
| DrugBank =
| C=15 | H=20 | F=1 | N=1 | O=1
| molecular_weight =
| smiles = FC1=CC=C(C=C1)C(C(CCC)N2CCCC2)=O
| ChemSpiderID = 9497595
| StdInChI = 1S/C15H20FNO/c1-2-5-14(17-10-3-4-11-17)15(18)12-6-8-13(16)9-7-12/h6-9,14H,2-5,10-11H2,1H3
| StdInChIKey = BQLSUBYYRRZHRK-UHFFFAOYSA-N
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = Class B
| legal_US = <!-- OTC / Rx-only  / Schedule I, II, III, IV, V -->
| routes_of_administration =
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 2417D71166
}}

'''4'-Fluoro-α-pyrrolidinopentiophenone''' (also known as '''FPVP''' and '''4-Fluoro-α-PVP''') is a [[stimulant]] drug of the [[Substituted cathinone|cathinone]] class which has been reported as a novel [[designer drug]].<ref>{{cite web | url=https://www.caymanchem.com/app/template/Product.vm/catalog/15166 | title= 4-fluoro-α-Pyrrolidinopentiophenone | publisher=Cayman Chemical}}</ref><ref>{{cite journal | vauthors = Uchiyama N, Matsuda S, Kawamura M, Shimokawa Y, Kikura-Hanajiri R, Aritake K, Urade Y, Goda Y | title = Characterization of four new designer drugs, 5-chloro-NNEI, NNEI indazole analog, α-PHPP and α-POP, with 11 newly distributed designer drugs in illegal products | journal = Forensic Sci. Int. | volume = 243 | pages = 1–13 | year = 2014 | pmid = 24769262 | doi = 10.1016/j.forsciint.2014.03.013 }}</ref>

==Legality==
4-F-α-PVP is illegal in China,<ref>{{cite web | url=http://www.sfda.gov.cn/WS01/CL0056/130753.html | title=关于印发《非药用类麻醉药品和精神药品列管办法》的通知 | publisher=China Food and Drug Administration | date=27 September 2015 | language=Chinese | accessdate=1 October 2015}}</ref> Hungary,<ref>[http://www.daath.hu/incoming/designer_jogi_lista_20150903_BSZKI_Daath_kieg.pdf A Magyarországon megjelent, a Kábítószer és Kábítószer-függőség Európai Megfigyelő Központjának Korai Jelzőrendszerébe (EMCDDA EWS) 2005 óta bejelentett ellenőrzött anyagok büntetőjogi vonatkozású besorolása]</ref> Japan,<ref>{{cite web | url=http://www.mhlw.go.jp/seisakunitsuite/bunya/kenkou_iryou/iyakuhin/yakubuturanyou/dl/meisho.pdf | title=指定薬物名称・構造式一覧（平成27年9月16日現在） | publisher=厚生労働省 | date=16 September 2015 | language=Japanese | accessdate=8 October 2015}}</ref> and the UK.

==See also==
* [[4'-Fluoro-α-pyrrolidinooctanophenone|4-Fluoro-α-POP]]
* [[Alpha-Pyrrolidinobutiophenone|α-PBP]]
* [[Alpha-Pyrrolidinohexiophenone|α-PHP]]
* [[Alpha-Pyrrolidinopropiophenone|α-PPP]]
* [[Alpha-Pyrrolidinopentiophenone|α-PVP]]
* [[Prolintane]]

==References==
{{reflist}}

{{stimulants}}

{{DEFAULTSORT:Fluoro-alpha-Pyrrolidinopentiophenone, 4'-}}

[[Category:Designer drugs]]
[[Category:Fluoroarenes]]
[[Category:Pyrrolidinophenones]]
[[Category:Norepinephrine-dopamine reuptake inhibitors]]
[[Category:Stimulants]]

{{nervous-system-drug-stub}}